Europe Transcatheter aortic valve replacement (TAVR) Market Overview
Transcatheter aortic valve replacement (TAVR) is described as a minimally invasive procedure replaces the improper functioning aortic valves. TAVR offers an efficient valve replacement procedure as compared to open-heart surgery for the benefit of high-risk patients. Transcatheter heart valve replacement systems are referred to as cardiovascular devices replace the old and damaged valves. TAVR is used for the treatment of aortic valve disorders such as severe aortic stenosis, degeneration, & regurgitation. Transcatheter aortic valve replacement devices are integrated with valve frame (made of nitinol or stainless steel), valve leaflets material (made of bovine or cow heart tissue). These aortic valves are available with varied sizes (such as 14mm, 16mm, 18mm, 20mm, 22mm, & 29mm). TAVR is performed during different surgery methods such as transfemoral implantation (through the femoral artery), transapical implantation (through the apex of the heart), transaortic implantation (through the top of right chest), and andtranscaval implantation (through the femoral vein).
Increasing technological advancements in biomedical engineering, the presence of advanced cardiovascular healthcare industry, existence of healthcare specialists & equipment, and growing demand for a healthy lifestyle are driving the growth of transcatheter aortic valve replacement (TAVR) market in Europe. However, stringent regulatory guidelines and the high cost of the TAVR procedures are expected to restrain the growth of transcatheter aortic valve replacement (TAVR) market in Europe.
Europe Transcatheter aortic valve replacement (TAVR) Market Forecast Report (2018-2023)
Europe Transcatheter aortic valve replacement (TAVR) market is expected to reach USD 1.47 billion by 2023 from USD 0.66 billion in 2018, growing at a CAGR of 17.40% during the forecast period 2018-2023.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/eu-transcatheter-aortic-valve-replacement-market-359/
Europe Transcatheter aortic valve replacement (TAVR) Market Segmentation
Europe transcatheter aortic valve replacement (TAVR) market is segmented based on surgery method, valve frame material, valve size, valve leaflets material, and end users. Based on surgery method, the market is sub-segmented as transfemoral implantation, transapical implantation, transaortic implantation, and transcaval implantation. Of these, transfemoral is estimated to command the largest share of Europe transcatheter aortic valve replacement (TAVR) market by surgery method in 2018 and expected to grow at the highest CAGR during the forecast period. Based on valve frame material, the market is segmented as nitinol, stainless steel, and cobalt-chromium. Of these, the nitinol segment is expected to account for the largest share of Europe transcatheter aortic valve replacement (TAVR) market by valve frame material in 2018.
On the basis of geographical areas, Europe transcatheter aortic valve replacement (TAVR) market is segmented as U.K., Germany, France, Italy, and Spain.
The major companies dominating this market for its products and services are
- Edwards Life sciences Corporation (U.S.),
- Medtronic, Inc. (Ireland),
- Boston Scientific Corporation (U.S.),
- Abbott Laboratories (U.S.),
- St. Jude Medical Inc. (U.S.),
- JenaValve Technology, Inc. (Germany),
- Symetis SA (Switzerland),
- Direct Flow Medical, Inc. (U.S.),
- Sorin Group (Italy),
- Meril Life Sciences India Pvt Ltd (India),
- Braile Biomedica (Brazil).
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
For more information:
Sales Manager at Market Data Forecast
Company Name: Market Data Forecast
Contact Person: Bhargav Moturi
Email: Send Email
Address:2nd Floor, Lakeview Plaza, Kavuri Hills 2 nd floor icici bank